Transthoracic and transesophageal echocardiography detected a left atrial mass attached to the intra-atrialseptum. Intravenous contrast agent ruled out atrial thrombus, sugesting a left atrial myxoma. This highlights theimportance of contrast echocardiography for differential diagnosis of left atrial findings.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
×
A transthoracic echocardiography in an 83-year-old woman revealed a thickening of the intra-atrial septum/mass in the LA (A). Further diagnostic via transesophageal echocardiography confirmed a 15 × 14 × 14 mm ball-shaped echo-inhomogeneous left-atrial mass originating from the intra-atrial septum without infiltration of adjacent structures (Panels C and D). Worm-like anechoic structures beside echo-dense areas and color-Doppler evaluation suggested blood vessels (Panel B). Intravenous SonoVue (Bracco Imaging) echo contrast agent was applied. It showed distribution from the right heart (E2) to the left atrium, initially sparing the intra-atrial septum mass (E3), before it adapted its echogenicity to the left atrial blood pool (E4)(Movie in data supplement).
Anzeige
Application of contrast agent allowed to rule out the differential diagnosis of an atrial thrombus, as only perfused tissue demonstrates uptake of contrast agent. Hence, diagnosis of left atrial myxoma was established. The good vascularization was later also demonstrated by coronary angiography. Due to her age and lack of clinical symptoms, the patient opted against surgery and for a watch-and-wait approach, as informed consent.
This examination should once again exemplify the value of contrast echocardiography - an image modality that in our opinion is too rarely used - as a low-threshold means to exclude relevant differential diagnoses and set the right path for the patient.
Declarations
Competing interests
The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.
Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.
Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.
Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.
Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.
Update Kardiologie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.